France· FR:61224073
EXACYL 500 mg, comprimé pelliculé
A medicinal product containing tranexamique (acide), registered in France by CHEPLAPHARM ARZNEIMITTEL (ALLEMAGNE), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- TRANEXAMIQUE (ACIDE)
- Manufacturer
- CHEPLAPHARM ARZNEIMITTEL (ALLEMAGNE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400932855520plaquette(s) PVC-Aluminium de 20 comprimé(s)EUR 2.79
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tranexamique (acide) in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenCyklo-f 500 mg Filmdragerad tablettViatris AB
- SpainACIDO TRANEXAMICO ZENTIVA 500 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFGZentiva K.S.
- NorwayCyklokapronViatris AS
- PolandDeporium ComfortAdamed Pharma S.A.
- NetherlandsCyklokapron, filmomhulde tabletten 500 mgViatris Healthcare B.V.
- IcelandCyklokapronViatris ApS
- IrelandCyklokapron 500 mg Film-coated TabletsViatris Healthcare Limited
- SwitzerlandTranexamic OrPha 500 mg, FilmtablettenOrPha Swiss GmbH
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Cyklokapron, Tranexamsäure Baxter
- Belgium · Acide Tranexamique Kabi, Cyklokapron
- Bulgaria · Медокапрон, Т-Капрон
- Cyprus · Azeptil, Medsamic
- Czechia · Exacyl, Tranexamic Acid Accord
- Germany · Cyklokapron, Cyklokapron-Injektionslösung
- Denmark · Cyklokapron, Cyklonova
- Estonia · Cyklokapron, Medsamic
- Spain · Ácido Tranexámico Baxter, Ácido Tranexámico Viatris
- Finland · Caprilon, Cyklokapron
- United Kingdom (Northern Ireland) · Cyklo-F, Cyklokapron
- Greece · Tranexamic Acid /Kabi, Tranexamic Acid Baxter
- Croatia · Medsamic, Trenolk
- Hungary · Exacyl, Nimra
- Ireland · Cyklokapron, Tranexamic Acid Accord Healthcare Ireland
- Iceland · Cyklokapron, Tranexamsyre Pfizer
- Italy · Acido Tranexamico Adamed, Acido Tranexamico Aurobindo
- Lithuania · Haixa, Tranexamic Acid Baxter
- Luxembourg · Exacyl, Tranexamsäure Dr. Eberth
- Latvia · Cyklokapron, Haixa
- Malta · Azeptil, Medsamic
- Netherlands · Cyklokapron, Nexag
- Norway · Cyklokapron, Pilexam
- Poland · Deporium, Deporium Comfort
- Portugal · Ácido Tranexâmico A.Forall, Ácido Tranexâmico Accord
- Romania · Acid Tranexamic Kabi, Medsamic
- Sweden · Cyklo-F, Cyklokapron
- Slovenia · Medsamic, Trenolk
- Slovakia · Medsamic, Tranexamic Acid Kabi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ab986aea-33b8-4b01-94db-e3936ecda76f GET /v1/drugs/ab986aea-33b8-4b01-94db-e3936ecda76f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "61224073",
"date_amm": "1986-01-27",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "TRANEXAMIQUE (ACIDE)",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about tranexamique (acide).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.